Equity Details
Price & Market Data
Price: $7.03
Daily Change: -$0.07 / 1.00%
Daily Range: $6.96 - $7.16
Market Cap: $244,030,688
Daily Volume: 106,271
Performance Metrics
1 Week: 4.61%
1 Month: 18.55%
3 Months: -9.76%
6 Months: -11.90%
1 Year: 12.12%
YTD: -8.70%
About Fennec Pharmaceuticals Inc. (FENC)
An extensive look into Fennec Pharmaceuticals Inc. (FENC). Current price: 7.03, daily change: -$0.07 / 1.00%. Market cap: 244,030,688. Performance from YTD to 1-year.
Company Details
Employees: 35
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.